- Home
- ELVN vs RHI Comparison
ELVN vs RHI Comparison
Compare ELVN & RHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ELVN | RHI |
|---|---|---|
| Founded | 2016 | 1948 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.6B |
| IPO Year | 2020 | 1994 |
Fundamental Metrics
Financial Performance| Metric | ELVN | RHI |
|---|---|---|
| Price | $41.49 | $26.37 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 7 |
| Target Price | ★ $43.40 | $30.33 |
| AVG Volume (30 Days) | 925.8K | ★ 2.8M |
| Earning Date | 05-11-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 8.68% |
| EPS Growth | ★ 3.17 | N/A |
| EPS | N/A | ★ 0.14 |
| Revenue | N/A | ★ $5,378,506,000.00 |
| Revenue This Year | N/A | $1.27 |
| Revenue Next Year | N/A | $5.95 |
| P/E Ratio | ★ N/A | $188.14 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $14.79 | $21.83 |
| 52 Week High | $48.53 | $48.54 |
Technical Indicators
Market Signals| Indicator | ELVN | RHI |
|---|---|---|
| Relative Strength Index (RSI) | 50.84 | 50.77 |
| Support Level | $16.84 | $25.93 |
| Resistance Level | $48.53 | $28.94 |
| Average True Range (ATR) | 2.29 | 1.48 |
| MACD | -0.97 | -0.10 |
| Stochastic Oscillator | 17.12 | 26.02 |
Price Performance
Historical ComparisonAbout ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. The product candidates of the company include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
About RHI Robert Half Inc.
Robert Half Inc was founded in 1948, Robert Half provides temporary, permanent, and outcome-based staffing for both in-person and remote positions in the finance and accounting, technology, legal, marketing, and administrative fields. Its subsidiary consulting arm, Protiviti, specializes in technology, risk, auditing, and compliance matters. The firm generates its sales inside the U.S. and is one of the specialized firms in the fragmented U.S. staffing industry.